Global Outbreaks and Travel Vaccination Update
Tomas Jelinek, MD, presented an overview of global vaccination recommendations at the DGIM 2026 Congress. He highlighted the rising risks of tick-borne encephalitis and measles, urging increased vaccination efforts. Additionally, he discussed the complexities surrounding dengue vaccination and the importance of assessing individual patient risks.
- ▪Tick-borne encephalitis (TBE) is now prevalent in many parts of Germany, with low adult vaccination rates.
- ▪Measles cases have surged in Europe since the COVID pandemic due to declining vaccination rates.
- ▪Japanese encephalitis is rare but severe, with vaccination recommended for certain travelers.
- ▪The yellow fever vaccine is recommended every 10 years, despite ongoing debates about its necessity.
- ▪Dengue vaccination remains controversial, with new vaccines available but incomplete protection.
Opening excerpt (first ~120 words) tap to expand
In his presentation at the 132nd Congress of the German Society for Internal Medicine (DGIM) 2026 in Wiesbaden, Germany, Tomas Jelinek, MD, medical director of the Berlin Centre for Travel and Tropical Medicine (BCRT) and the scientific director of the Centre for Travel and Tropical Medicine in Düsseldorf, Germany, gave a brief overview of the global epidemiologic situation and recommendations for travel-related vaccinations.Underestimated Tick-Borne Encephalitis (TBE) Risk“You don’t have to travel at all for tick-borne encephalitis (TBE),” Jelinek began. “The weather is nice, the season is starting, and we’re already seeing the first patients with tick bites.” TBE now occurs in large parts of Germany.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.
Discussion
0 commentsMore from Medscape
